Stock Earnings

Question 1

How did RARE's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Ultragenyx Pharmaceutical Inc is $-1.81, beating expectations of $-1.25.

Question 2

How did Ultragenyx Pharmaceutical Inc RARE's revenue perform in the last quarter?

Accepted Answer

Ultragenyx Pharmaceutical Inc revenue for the last quarter is $-1.81

Question 3

What is the revenue estimate for Ultragenyx Pharmaceutical Inc?

Accepted Answer

According to 19 of Wall street analyst, the revenue estimate of Ultragenyx Pharmaceutical Inc range from $207.36M to $168.63M

Question 4

What's the earning quality score for Ultragenyx Pharmaceutical Inc?

Accepted Answer

Ultragenyx Pharmaceutical Inc has a earning quality score of B+/49.704926. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Ultragenyx Pharmaceutical Inc report earnings?

Accepted Answer

Ultragenyx Pharmaceutical Inc next earnings report is expected in 2026-02-02

Question 6

What are Ultragenyx Pharmaceutical Inc's expected earnings?

Accepted Answer

Ultragenyx Pharmaceutical Inc expected earnings is $170.04M, according to wall-street analysts.

Question 7

Did Ultragenyx Pharmaceutical Inc beat earnings expectations?

Accepted Answer

Ultragenyx Pharmaceutical Inc recent earnings of $159.93M does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-1.25	$-1.81	+44.8%	BEAT
Q2 '25	$-1.32	$-1.17	-11.36%	MISSED
Q1 '25	$-1.64	$-1.57	-4.26%	MISSED
Q4 '24	$-1.31	$-1.39	+6.1%	BEAT
Q3 '24	$-1.47	$-1.4	-4.76%	MISSED

Ultragenyx Pharmaceutical Inc (RARE) Price

RARE Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ